Histogen Announces Board Approval of Complete Liquidation and Dissolution

Stock Information for Sonnet BioTherapeutics Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Sonnet BioTherapeutics Holdings Inc.

Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering
Histogen Announces Second Adjournment of Special Meeting of Stockholders
Histogen Announces Adjournment of Special Meeting of Stockholders
Histogen to Explore Strategic Alternatives
Histogen Reports First Quarter 2023 Results and Provides Business Update
Histogen Announces Online Publication in the Journal of Investigative Dermatology
Histogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins University
Histogen Announces Issuance of US Patent Covering CTS-2090 Methods of Use

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.